A Copernican revolution in neuropathology. Implications of the discovery of lesions in the nucleus basalis in Alzheimer's disease
Muñoz García, D.
Archivos de Neurobiologia 46(3): 159-160
1983
ISSN/ISBN: 0004-0576 PMID: 6639274 Document Number: 201611
Document emailed within 1 workday
Related Documents
Arai, H.; Iizuka, R. 1988: Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1491-1495Li, L.; An, X.; Qiao, J. 1998: Pathological characteristic of Alzheimer's disease produced by lesion in nucleus basalis of Meynert in rats Chinese Medical Journal 111(7): 638-640
Katayama, S.; Kito, S.; Yamamura, Y. 1990: Increase of muscarinic receptor following kainic acid lesions of the nucleus basalis magnocellularis in rat brain: an autoradiographic study Research Communications in Chemical Pathology and Pharmacology 68(3): 391-394
Panocka, I.; Coppi, G.; Maggioni, A.; Olgiati, V.; Sabbatini, M.; Amenta, F. 1997: Effect of the thyrotropin releasing hormone analogue posatirelin (RGH 2202) on microanatomical changes induced by lesions of the nucleus basalis magnocellularis in the rat Drugs under Experimental and Clinical Research 23(1): 13-23
Mandel, R.J.; Chen, A.D.; Connor, D.J.; Thal, L.J. 1989: Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers Journal of Pharmacology and Experimental Therapeutics 251(2): 612-619
Murayam, S.; Saito, Y. 2007: Neuropathology of mild cognitive impairment Alzheimer's disease Rinsho Shinkeigaku 47(11): 912-914
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299
Szenborn, M. 1993: Neuropathological study on the nucleus basalis of Meynert in mature and old age Patologia Polska 44(4): 211-216
Kovacs, G.G.; Gelpi, E. 2012: Clinical neuropathology practice news 3-2012: the "ABC" in AD-revised and updated guideline for the neuropathologic assessment of Alzheimer's disease Clinical neuropathology 31(3): 116-118
Abdulla, F.; Dawe, G.; Scorsa, A.M.; Rispoli, V.; Stephenson, J.D. 1992: Effects of tetrahydro-9-aminoacridine on the electrocorticogram of rats with a unilateral lesion of the nucleus basalis magnocellularis Functional Neurology 7(2): 141-144
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Mannen, T. 1991: Neuropathology of Onuf's nucleus Rinsho Shinkeigaku 31(12): 1281-1285
Chan-Palay, V. 1990: Hyperinnervation of surviving neurons of the human basal nucleus of meynert by galanin in dementias of Alzheimer's and Parkinson's disease Advances in Neurology 51: 253-255
Mitsuyama, Y. 1982: Alzheimer's disease associated with arteriosclerotic cerebrovascular lesions Seishin Shinkeigaku Zasshi 84(3): 184-197
Defossez, A.; Persuy, P.; Tramu, G.; Delacourte, A. 1986: Immunohistochemical study of the basic lesions of Alzheimer's disease L'Encephale 12(4): 161-168
Cutler, N.R.; Sramek, J.J. 1998: Exploratory studies: implications for drug development in Alzheimer's disease Revue Neurologique (Paris) 154(Suppl): S131-S136
Habib, M'gasseb. 2009: The discovery of penicillin: a revolution in the treatment of syphilis La Tunisie Medicale 87(6): 369-371
Brion, J.P. 1992: Cellular lesions in Alzheimer's disease: structural and molecular analysis Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 147(11-12): 481-489; Discussion: 490-491
Farlow, M.R. 2001: Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine Clinical Therapeutics 23(Suppl): A13-A24
Beeley, N.; Berger, A. 2000: A revolution in drug discovery. Combinatorial chemistry still needs logic to drive science forward Bmj 321(7261): 581-582